Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinomaG. Deplanque, Adrian L. Harris, K Christodoulos et al.|British Journal of Cancer|2004Cited by 20
A randomised phase II study of interferon alpha alone or in combination with thalidomide in metastatic renal cancerSrinivasan Madhusudan, Adrian L. Harris, Andrew Protheroe et al.|Journal of Clinical Oncology|2004Cited by 5